Cardiovascular

Global burden of chronic kidney disease attributable to hypertension due to high body mass index: projections to 2050.

TL;DR

The high BMI-attributable burden of hypertension-related CKD increased substantially from 1990 to 2021, remains unequally distributed, and is projected to keep rising to 2050, supporting integrated obesity prevention and hypertension control with priority for high-risk regions and older adults.

Key Findings

Global deaths and DALYs from hypertension-related CKD attributable to high BMI rose sharply between 1990 and 2021.

  • Attributable deaths increased from 36,476 in 1990 to 179,788 in 2021.
  • DALYs increased from 1.01 million to 4.26 million.
  • Data came from the Global Burden of Disease (GBD) 2021 study for 1990-2021.

Age-standardized mortality and disability-adjusted life-year rates both increased over the study period.

  • ASMR increased from 1.09 to 2.19 per 100,000 (EAPC, 4.22%).
  • ASDR increased from 26.04 to 50.11 per 100,000 (EAPC, 3.63%).
  • Temporal trends were assessed using the estimated annual percentage change (EAPC).

Regional burden varied, with Central Sub-Saharan Africa having the highest ASMR and High-income North America the fastest increase.

  • Central Sub-Saharan Africa had the highest ASMR (7.66 per 100,000).
  • High-income North America had the fastest increase in ASMR (EAPC, 5.63%).

Men had higher age-standardized rates than women, and the age patterns of deaths and DALYs differed.

  • ASMR and ASDR were higher in men than in women.
  • Death counts peaked at ages 85-89 years in both sexes.
  • DALYs peaked at ages 60-64 years in men and 65-69 years in women.

Crude rates were higher in higher-SDI populations, but the relative burden became more concentrated in lower-SDI populations over time.

  • Concentration indices changed from -0.10 to -0.17 for deaths.
  • Concentration indices changed from -0.06 to -0.08 for DALYs.
  • Negative values indicate a growing concentration in lower-SDI populations.

Bayesian age-period-cohort projections indicate the age-standardized burden will continue to rise to 2050.

  • ASMR is projected to reach 4.44 per 100,000 (95% CI, 3.70-5.20) by 2050.
  • ASDR is projected to reach 77.15 per 100,000 (95% CI, 1.81-152.49).
  • The ASDR credible interval is very wide, indicating considerable projection uncertainty.

The study concludes the burden is increasing and unequally distributed and supports integrated prevention and control strategies.

  • Recommends integrated obesity prevention and hypertension control.
  • Priority is suggested for high-risk regions and older adults.
  • Background: CKD affects approximately 9.1% of the global population (about 843 million people in 2021), with hypertension a major contributor.

What This Means

This study used data from the Global Burden of Disease project to look at how much kidney disease caused by high blood pressure can be traced to high body weight (high BMI). Between 1990 and 2021, deaths from this cause rose about fivefold, from roughly 36,000 to nearly 180,000 per year, and lost healthy life years rose from about 1 million to 4.3 million. Even after adjusting for population aging and growth, the death rate roughly doubled. The burden differed by place, sex, and age. Central Sub-Saharan Africa had the highest death rate, while High-income North America saw the fastest increase. Men had higher rates than women. Deaths were most common at ages 85-89, while lost healthy years peaked in the early to late 60s. Countries with higher development levels had higher crude rates, but over time the relative burden shifted toward less-developed populations. Projections suggest the death rate could roughly double again by 2050, to about 4.4 per 100,000, though projections are uncertain, especially for lost healthy life years. This research suggests that tackling obesity and high blood pressure together, with attention to higher-risk regions and older adults, may help limit the growing burden. As a modeling study based on estimated data, it describes patterns rather than proving cause and effect for individuals.

Have a question about this study?

Citation

Li L, Zhu G, Wang K, Maimaiti S, Wang S, Lu C. (2026). Global burden of chronic kidney disease attributable to hypertension due to high body mass index: projections to 2050.. Renal failure. https://doi.org/10.1080/0886022X.2026.2751889